Gene: ALDH4A1
Official Full Name: aldehyde dehydrogenase 4 family member A1provided by HGNC
Gene Summary: This protein belongs to the aldehyde dehydrogenase family of proteins. This enzyme is a mitochondrial matrix NAD-dependent dehydrogenase which catalyzes the second step of the proline degradation pathway, converting pyrroline-5-carboxylate to glutamate. Deficiency of this enzyme is associated with type II hyperprolinemia, an autosomal recessive disorder characterized by accumulation of delta-1-pyrroline-5-carboxylate (P5C) and proline. Alternatively spliced transcript variants encoding different isoforms have been identified for this gene. [provided by RefSeq, Jun 2009]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO33968 | ALDH4A1 Knockout cell line (HeLa) | Human | ALDH4A1 | 1:3~1:6 | Negative | Online Inquiry |
KO33969 | ALDH4A1 Knockout cell line (HCT 116) | Human | ALDH4A1 | 1:2~1:4 | Negative | Online Inquiry |
KO33970 | ALDH4A1 Knockout cell line (HEK293) | Human | ALDH4A1 | 1:3~1:6 | Negative | Online Inquiry |
KO33971 | ALDH4A1 Knockout cell line (A549) | Human | ALDH4A1 | 1:3~1:4 | Negative | Online Inquiry |
ALDH4A1 Gene Knockout Cell Lines are specifically engineered cell models that lack the expression of the aldehyde dehydrogenase 4A1 gene, a critical enzyme involved in the metabolism of aldehydes and glutamate. The absence of ALDH4A1 provides researchers with a unique tool to study its physiological roles, elucidate metabolic pathways, and assess the gene's involvement in various disease processes, particularly neurological disorders and oxidative stress responses.
These cell lines function by serving as a platform to investigate the effects of ALDH4A1 deficiency on cellular metabolism, growth, and differentiation. By employing gene editing techniques, such as CRISPR-Cas9, to achieve targeted knockout, scientists can create reproducible models that facilitate the dissection of gene function in a controlled environment. This allows for a deeper understanding of the consequences of ALDH4A1 loss, including potential alterations in cellular homeostasis and the impacts on key signaling pathways.
The scientific importance of ALDH4A1 Gene Knockout Cell Lines extends across several domains, including pharmacology, toxicology, and gene therapy research. They provide invaluable insights into the biochemical mechanisms underlying diseases linked to aldehyde metabolism, thus informing therapeutic strategies that could mitigate disease progression.
Compared to traditional cell lines, our ALDH4A1 knockouts are characterized by their reproducibility, specificity, and robustness, making them an essential asset in cellular research. Unlike alternatives that may not accurately reflect the gene's absence, our models are validated for consistent expression profiles and phenotypic characteristics, providing researchers with reliable data.
For researchers and clinicians aiming to enhance their understanding of metabolic diseases or develop targeted therapies, ALDH4A1 Gene Knockout Cell Lines offer a powerful resource that bridges the gap between fundamental research and clinical applications. With our extensive expertise in genetic engineering and commitment to advancing biological research, our company is dedicated to providing high-quality, innovative products that empower scientific discovery.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.